Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Levels of circulating microparticles in lung cancer patients and possible prognostic value.

Tseng CC, Wang CC, Chang HC, Tsai TH, Chang LT, Huang KT, Leu S, Yen CH, Liu SF, Chen CH, Yang CT, Yip HK, Lin MC.

Dis Markers. 2013;35(5):301-10. doi: 10.1155/2013/715472. Epub 2013 Sep 15.

2.

Circulating endothelial-derived activated microparticle: a useful biomarker for predicting one-year mortality in patients with advanced non-small cell lung cancer.

Wang CC, Tseng CC, Hsiao CC, Chang HC, Chang LT, Fang WF, Leu S, Wang YH, Tsai TH, Yang CT, Chen CH, Yip HK, Ho CK, Lin MC.

Biomed Res Int. 2014;2014:173401. doi: 10.1155/2014/173401. Epub 2014 Jun 29.

3.

Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention.

Tseng CC, Wang CC, Hsiao CC, Lu HI, Leu S, Chang HC, Huang KT, Fang WF, Chen YM, Liu SF, Yang CT, Lin MC, Yip HK.

Tumour Biol. 2016 Sep;37(9):11873-11882. Epub 2016 Apr 8.

PMID:
27059732
4.

Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer.

Fleitas T, Martínez-Sales V, Vila V, Reganon E, Mesado D, Martín M, Gómez-Codina J, Montalar J, Reynés G.

PLoS One. 2012;7(10):e47365. doi: 10.1371/journal.pone.0047365. Epub 2012 Oct 15.

5.

Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.

Campello E, Spiezia L, Radu CM, Bulato C, Castelli M, Gavasso S, Simioni P.

Thromb Res. 2011 May;127(5):473-7. doi: 10.1016/j.thromres.2011.01.002. Epub 2011 Jan 22.

PMID:
21256535
6.

Administered circulating microparticles derived from lung cancer patients markedly improved angiogenesis, blood flow and ischemic recovery in rat critical limb ischemia.

Sheu JJ, Lee FY, Wallace CG, Tsai TH, Leu S, Chen YL, Chai HT, Lu HI, Sun CK, Yip HK.

J Transl Med. 2015 Feb 15;13:59. doi: 10.1186/s12967-015-0381-8.

7.

The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis.

Berezin AE, Kremzer AA, Berezina TA, Martovitskaya YV.

Acta Clin Belg. 2016 Feb;71(1):38-45. doi: 10.1080/17843286.2015.1110894. Epub 2016 Feb 3.

PMID:
27075791
8.

CD235a (Glycophorin-A) Is the Most Predictive Value Among Different Circulating Cellular Microparticles in Thrombocytopenic Human Immunodeficiency Virus Type 1.

El-Menshawy N, Eissa M, Farag R, Aboalyazed A.

J Clin Lab Anal. 2016 May;30(3):235-43. doi: 10.1002/jcla.21842. Epub 2015 Feb 25.

PMID:
25716234
9.

Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay.

Ayers L, Kohler M, Harrison P, Sargent I, Dragovic R, Schaap M, Nieuwland R, Brooks SA, Ferry B.

Thromb Res. 2011 Apr;127(4):370-7. doi: 10.1016/j.thromres.2010.12.014. Epub 2011 Jan 22.

PMID:
21257195
10.

Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus.

Nielsen CT, Østergaard O, Johnsen C, Jacobsen S, Heegaard NH.

Arthritis Rheum. 2011 Oct;63(10):3067-77. doi: 10.1002/art.30499.

11.

Elevated Level of Circulating Platelet-derived Microparticles in Oral Cancer.

Ren JG, Man QW, Zhang W, Li C, Xiong XP, Zhu JY, Wang WM, Sun ZJ, Jia J, Zhang WF, Zhao YF, Chen G, Liu B.

J Dent Res. 2016 Jan;95(1):87-93. doi: 10.1177/0022034515592593. Epub 2015 Jun 29.

PMID:
26124218
12.

Young women with polycystic ovary syndrome have raised levels of circulating annexin V-positive platelet microparticles.

Willis GR, Connolly K, Ladell K, Davies TS, Guschina IA, Ramji D, Miners K, Price DA, Clayton A, James PE, Rees DA.

Hum Reprod. 2014 Dec;29(12):2756-63. doi: 10.1093/humrep/deu281. Epub 2014 Oct 21.

PMID:
25336711
13.

Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.

Sellam J, Proulle V, Jüngel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X.

Arthritis Res Ther. 2009;11(5):R156. doi: 10.1186/ar2833. Epub 2009 Oct 15.

14.

Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value.

Reynés G, Vila V, Fleitas T, Reganon E, Font de Mora J, Jordá M, Martínez-Sales V.

PLoS One. 2013 Jul 29;8(7):e69034. doi: 10.1371/journal.pone.0069034. Print 2013.

15.

A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies.

Niccolai E, Squatrito D, Emmi G, Silvestri E, Emmi L, Ciucciarelli L, Ricci F, Manganaro D, Amedei A, Prisco D.

Thromb Res. 2015 Dec;136(6):1252-8. doi: 10.1016/j.thromres.2015.10.018. Epub 2015 Oct 14.

PMID:
26476741
16.

A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer.

Iversen LV, Ostergaard O, Nielsen CT, Jacobsen S, Heegaard NH.

J Immunol Methods. 2013 Feb 28;388(1-2):49-59. doi: 10.1016/j.jim.2012.12.001. Epub 2012 Dec 12.

PMID:
23246793
17.

Levels of circulating microparticles in patients with chronic cardiorenal disease.

Chen YL, Chen CH, Wallace CG, Wang HT, Yang CC, Yip HK.

J Atheroscler Thromb. 2015;22(3):247-56. doi: 10.5551/jat.26658. Epub 2014 Oct 22.

18.

Characterization of microparticles after hepatic ischemia-reperfusion injury.

Freeman CM, Quillin RC 3rd, Wilson GC, Nojima H, Johnson BL 3rd, Sutton JM, Schuster RM, Blanchard J, Edwards MJ, Caldwell CC, Lentsch AB.

PLoS One. 2014 May 30;9(5):e97945. doi: 10.1371/journal.pone.0097945. eCollection 2014.

19.

Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.

Iversen LV, Østergaard O, Ullman S, Nielsen CT, Halberg P, Karlsmark T, Heegaard NH, Jacobsen S.

Scand J Rheumatol. 2013;42(6):473-82. doi: 10.3109/03009742.2013.796403. Epub 2013 Sep 9.

PMID:
24016306
20.

Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection.

Punyadee N, Mairiang D, Thiemmeca S, Komoltri C, Pan-Ngum W, Chomanee N, Charngkaew K, Tangthawornchaikul N, Limpitikul W, Vasanawathana S, Malasit P, Avirutnan P.

J Virol. 2015 Feb;89(3):1587-607. doi: 10.1128/JVI.02207-14. Epub 2014 Nov 19.

Supplemental Content

Support Center